The European Association for the Study of Diabetes (EASD) offers a fascinating interdisciplinary mix of attendees enabling exciting opportunities for scientific discussion and debate. In 2019, the 55th Annual Meeting of the EASD was again held in the beautiful city of Barcelona. Below, you can watch videos taken from the Novartis-sponsored satellite symposium “VERIFY: What change are you bringing to overcome clinical inertia?”
How important is it to achieve early glycaemic control in patients with type 2 diabetes and how does clinical inertia impact these patients? Discover what Professor Kamlesh Khunti and Professor Mark Cooper have to say along with the patient’s perspective from Mrs. Delia Gooding.
How can we reduce the risk of progression and development of microvascular complications in type 2 diabetes patients? Could achieving better early glycaemic control through combination therapy be the answer? Learn more from Professor Paola Fioretto as she shares her interpretation of the VERIFY trial, with a patient’s perspective kindly provided by Mrs. Delia Gooding.
Discover more about the VERIFY trial including information on the rationale, study design and key results. Who was included in the study and which patients benefit from early combination therapy? Find out the views of Professor Michael Stumvoll and Professor Juliana Chan.
Alternatively login via
Back to epgonline.org